Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ACHN

Achillion Pharmaceuticals (ACHN) Stock Price, News & Analysis

Achillion Pharmaceuticals logo

About Achillion Pharmaceuticals Stock (NASDAQ:ACHN)

Advanced Chart

Key Stats

Today's Range
$6.76
$6.76
50-Day Range
$6.76
$6.76
52-Week Range
$2.06
$7.01
Volume
N/A
Average Volume
8.44 million shs
Market Capitalization
$946.72 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ACHN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Achillion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

ACHN Stock News Headlines

Kim P. Kamdar's Net Worth
Lexicon Pharmaceuticals (NASDAQ: LXRX)
Altucher: Trump’s Great Gain is starting
New Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Trump’s Great Gain” has officially begun. Altucher believes select cryptos could turn $900 into $108,000 over the next 12 months — and he’s laying out the full gameplan in a new presentation.
ACHN_old Historical Data
See More Headlines

ACHN Stock Analysis - Frequently Asked Questions

Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) issued its quarterly earnings results on Thursday, November, 7th. The biopharmaceutical company reported ($0.14) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.16) by $0.02.

Based on aggregate information from My MarketBeat watchlists, some other companies that Achillion Pharmaceuticals investors own include Chesapeake Energy (CHKAQ), Skyworks Solutions (SWKS), Madrigal Pharmaceuticals (MDGL), Noble (NEBLQ), Gilead Sciences (GILD), Eiger BioPharmaceuticals (EIGR) and Meta Platforms (META).

Company Calendar

Last Earnings
11/07/2019
Today
7/18/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:ACHN
CIK
1070336
Fax
N/A
Employees
56
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
($0.51)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$70.27 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-30.95%
Return on Assets
-29.09%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
8.96
Quick Ratio
8.96

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.92 per share
Price / Book
3.52

Miscellaneous

Outstanding Shares
140,047,000
Free Float
N/A
Market Cap
$946.72 million
Optionable
Optionable
Beta
1.59
These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report

This page (NASDAQ:ACHN) was last updated on 7/18/2025 by MarketBeat.com Staff
From Our Partners